Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) had Return on Tangible Equity of -69.72% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.81M |
|
-- |
|
-- |
|
$3.96M |
|
$-3.96M |
|
$0.14M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
$-3.81M |
|
$-3.96M |
|
$-3.93M |
|
0.59M |
|
0.59M |
|
$-6.50 |
|
$-6.50 |
|
| Balance Sheet Financials | |
$12.50M |
|
-- |
|
$0.46M |
|
$12.96M |
|
$4.86M |
|
-- |
|
$2.17M |
|
$7.03M |
|
$5.93M |
|
$5.47M |
|
$5.93M |
|
0.59M |
|
| Cash Flow Statement Financials | |
$-2.59M |
|
$2.77M |
|
$0.02M |
|
$3.62M |
|
$3.82M |
|
$0.20M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-64.33% |
|
|
Return on Tangible Equity |
-69.72% |
-29.43% |
|
-64.33% |
|
$10.08 |
|
$-4.42 |
|
$-4.42 |
|